Search for: "Sandoz, Inc" Results 61 - 80 of 680
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jul 2020, 9:49 pm by Patent Docs
The Federal Circuit, in a fractured decision reminiscent of the alignment of the judges in Amgen v Sandoz, remedied this situation in its decision last Friday in Gensetix, Inc. v. [read post]
7 Jul 2020, 9:15 am by Rebecca Tapscott
Sandoz, Inc., Sandoz International GMBH, Sandoz GMBH, holding that Sandoz failed to prove that the asserted claims were invalid for obviousness-type double patenting (ODP), failure to meet the written description requirement, and obviousness for lack of motivation to combine... [read post]
7 Jul 2020, 9:15 am by Rebecca Tapscott
Sandoz, Inc., Sandoz International GMBH, Sandoz GMBH, holding that Sandoz failed to prove that the asserted claims were invalid for obviousness-type double patenting (ODP), failure to meet the written description requirement, and obviousness for lack of motivation to combine the prior art references. [read post]
22 Nov 2019, 2:56 pm by Lawrence B. Ebert
Sandoz, Inc., 135 S.Ct. 831, 841 (2015).Of issue preclusionA leading treatise states that, as a general rule, “preclusion applies to any issue framed by the pleadings andnot withdrawn, even though it has not been raised at trialin any way. [read post]
27 Sep 2019, 11:50 am by Brianna Smith
Sandoz Inc. is recalling certain lots of a generic version of Zantac that may be contaminated with a cancer-causing agent. [read post]
5 Sep 2019, 9:59 pm by Patent Docs
Sandoz Inc. earlier this year, regarding the doctrine of equivalents, which the Court corrected yesterday on Amgen's petition for rehearing regarding the panel opinion. [read post]